{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:19:47Z","timestamp":1790104787306,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Center for Advancing Translational Sciences of the National Institute of Health Award","award":["UL1TR000114"],"award-info":[{"award-number":["UL1TR000114"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS086312"],"award-info":[{"award-number":["R01NS086312"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10928-019-09657-0","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T09:04:59Z","timestamp":1570179899000},"page":"565-576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis"],"prefix":"10.1007","volume":"46","author":[{"name":"ASTRO-CM Study Team","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4008-7011","authenticated-orcid":false,"given":"Ali A.","family":"Alhadab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Rhein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Tugume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdu","family":"Musubire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlisha A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Abassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie R.","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Meya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Boulware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Brundage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"9657_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8Elsevier","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR (2017) Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 17:873\u2013881. \nhttps:\/\/doi.org\/10.1016\/S1473-3099(17)30243-8Elsevier","journal-title":"Lancet Infect Dis"},{"key":"9657_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","volume":"23","author":"BJ Park","year":"2009","unstructured":"Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS. Aids 23:525\u2013530. \nhttps:\/\/doi.org\/10.1097\/QAD.0b013e328322ffac","journal-title":"Aids"},{"key":"9657_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","volume":"16","author":"J Rhein","year":"2016","unstructured":"Rhein J, Morawski BM, Hullsiek KH, Nabeta HW, Kiggundu R, Tugume L, Musubire A, Akampurira A, Smith KD, Alhadab A, Williams DA, Abassi M, Bahr NC, Velamakanni SS, Fisher J, Nielsen K, Meya DB, Boulware DR, Ndyetukira JF, Ahimbisibwe C, Kugonza F, Sadiq A, Kandole TK, Luggya T, Kaboggoza J, Laker E, Butler EK, Dyal J, Neborak JM, King AM, Fujita AW, Yueh N, Namudde A, Halupnick R, Jawed B, Vedula P, Peterson M, Bohjanen PR, Kambugu A (2016) Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study. Lancet Infect Dis 16:809\u2013818. \nhttps:\/\/doi.org\/10.1016\/S1473-3099(16)00074-8","journal-title":"Lancet Infect Dis"},{"key":"9657_CR4","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","volume":"370","author":"DR Boulware","year":"2014","unstructured":"Boulware DR, Meya DB, Muzoora C, Rolfes MA, Huppler Hullsiek K, Musubire A, Taseera K, Nabeta HW, Schutz C, Williams DA, Rajasingham R, Rhein J, Thienemann F, Lo MW, Nielsen K, Bergemann TL, Kambugu A, Manabe YC, Janoff EN, Bohjanen PR, Meintjes G (2014) Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med 370:2487\u20132498. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1312884","journal-title":"N Engl J Med"},{"key":"9657_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/cid\/cit794","volume":"58","author":"JN Jarvis","year":"2014","unstructured":"Jarvis JN, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum JC, Longley N, Muzoora C, Phulusa J, Taseera K, Kanyembe C, Wilson D, Hosseinipour MC, Brouwer AE, Limmathurotsakul D, White N, Van Der Horst C, Wood R, Meintjes G, Bradley J, Jaffar S, Harrison T (2014) Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis 58:736\u2013745. \nhttps:\/\/doi.org\/10.1093\/cid\/cit794","journal-title":"Clin Infect Dis"},{"key":"9657_CR6","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","volume":"368","author":"JN Day","year":"2013","unstructured":"Day JN, Chau TTH, Wolbers M, Mai PP, Dung NT, Mai NH, Phu NH, Nghia HD, Phong ND, Thai CQ, Thai LH, Chuong LV, Sinh DX, Duong VA, Hoang TN, Diep PT, Campbell JI, Sieu TPM, Baker SG, Chau NVV, Hien TT, Lalloo DG, Farrar JJ (2013) Combination antifungal therapy for cryptococcal meningitis. N Engl J Med 368:1291\u20131302. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1110404","journal-title":"N Engl J Med"},{"key":"9657_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/mmy\/myv109","volume":"54","author":"RDJ Trevino-Rangel","year":"2016","unstructured":"Trevino-Rangel RDJ, Villanueva-Lozano H, Hernandez-Rodriguez P, Martinez-Resendez MF, Garcia-Juarez J, Rodriguez-Rocha H, Gonzalez GM (2016) Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays. Med Mycol 54:280\u2013286. \nhttps:\/\/doi.org\/10.1093\/mmy\/myv109","journal-title":"Med Mycol"},{"key":"9657_CR8","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.1128\/AAC.01299-15.Address","volume":"59","author":"KD Smith","year":"2015","unstructured":"Smith KD, Achan B, Hullsiek KH, Mcdonald TR, Okagaki LH, Alhadab AA, Akampurira A, Rhein JR, Meya DB, Boulware DR, Nielsen K (2015) Increased antifungal drug resistance in clinical isolates of Cryptococcus neoformans in Uganda. Antimicrob Agents Chemother 59:7197\u20137204. \nhttps:\/\/doi.org\/10.1128\/AAC.01299-15.Address","journal-title":"Antimicrob Agents Chemother"},{"key":"9657_CR9","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1128\/AAC.00212-12","volume":"56","author":"B Zhai","year":"2012","unstructured":"Zhai B, Wu C, Wang L, Sachs MS, Lin X (2012) The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections. Antimicrob Agents Chemother 56:3758\u20133766. \nhttps:\/\/doi.org\/10.1128\/AAC.00212-12","journal-title":"Antimicrob Agents Chemother"},{"key":"9657_CR10","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1158\/0008-5472.CAN-09-4072","volume":"70","author":"C-JJ Lin","year":"2010","unstructured":"Lin C-JJ, Robert F, Sukarieh R, Michnick S, Pelletier J (2010) The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling. Cancer Res 70:3199\u20133208. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4072","journal-title":"Cancer Res"},{"key":"9657_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/jac\/dkg184","volume":"51","author":"TJ Young","year":"2003","unstructured":"Young TJ, Oliver GP, Pryde D, Perros M, Parkinson T (2003) Antifungal activity of selective serotonin reuptake inhibitors attributed to non-specific cytotoxicity. J Antimicrob Chemother 51:1045\u20131047. \nhttps:\/\/doi.org\/10.1093\/jac\/dkg184","journal-title":"J Antimicrob Chemother"},{"key":"9657_CR12","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1534\/genetics.110.117846","volume":"185","author":"MM Rainey","year":"2010","unstructured":"Rainey MM, Korostyshevsky D, Lee S, Perlstein EO (2010) The antidepressant sertraline targets intracellular vesiculogenic membranes in yeast. Genetics 185:1221\u20131233. \nhttps:\/\/doi.org\/10.1534\/genetics.110.117846","journal-title":"Genetics"},{"key":"9657_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijantimicag.2005.07.006","volume":"26","author":"A Mayr","year":"2005","unstructured":"Mayr A, Hinterberger G, Dierich MP, Lass-Fl\u00f6rl C (2005) Interaction of serotonin with Candida albicans selectively attenuates fungal virulence in vitro. Int J Antimicrob Agents 26:335\u2013337. \nhttps:\/\/doi.org\/10.1016\/j.ijantimicag.2005.07.006","journal-title":"Int J Antimicrob Agents"},{"key":"9657_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ijantimicag.2004.03.021","volume":"24","author":"I Heller","year":"2004","unstructured":"Heller I, Leitner S, Dierich MP, Lass-Fl\u00f6rl C (2004) Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro. Int J Antimicrob Agents 24:401\u2013404. \nhttps:\/\/doi.org\/10.1016\/j.ijantimicag.2004.03.021","journal-title":"Int J Antimicrob Agents"},{"key":"9657_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/21501203.2010.487054","volume":"1","author":"R Nayak","year":"2010","unstructured":"Nayak R, Xu J (2010) Effects of sertraline hydrochloride and fluconazole combinations on Cryptococcus neoformans and Cryptococcus gattii. Mycology 1:99\u2013105. \nhttps:\/\/doi.org\/10.1080\/21501203.2010.487054","journal-title":"Mycology"},{"key":"9657_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JRR Perfect","year":"2010","unstructured":"Perfect JRR, Dismukes WEE, Dromer F, Goldman DLL, Graybill JRR, Hamill RJJ, Harrison TSS, Larsen RA, Lortholary O, Nguyen MM-H, Pappas PGG, Powderly WGG, Singh N, Sobel JDD, Sorrell TCC (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases Society of America. Clin Infect Dis 50:291\u2013322. \nhttps:\/\/doi.org\/10.1086\/649858","journal-title":"Clin Infect Dis"},{"key":"9657_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/msb.2011.31","volume":"7","author":"M Spitzer","year":"2014","unstructured":"Spitzer M, Griffiths E, Blakely KM, Wildenhain J, Ejim L, Rossi L, De Pascale G, Curak J, Brown E, Tyers M, Wright GD (2014) Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole. Mol Syst Biol 7:499. \nhttps:\/\/doi.org\/10.1038\/msb.2011.31","journal-title":"Mol Syst Biol"},{"key":"9657_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/jat\/bkt014","volume":"37","author":"RJ Lewis","year":"2013","unstructured":"Lewis RJ, Angier MK, Williamson KS, Johnson RD (2013) Analysis of sertraline in postmortem fluids and tissues in 11 aviation accident victims. J Anal Toxicol 37:208\u2013216. \nhttps:\/\/doi.org\/10.1093\/jat\/bkt014","journal-title":"J Anal Toxicol"},{"key":"9657_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mpr.125","volume":"11","author":"M Orlando","year":"2002","unstructured":"Orlando M, Burnam MA, Beckman R, Morton SC, London AS, Bing EG, Fleishman JA, Health R (2002) Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res 11:75\u201382","journal-title":"Int J Methods Psychiatr Res"},{"key":"9657_CR20","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1080\/09540121.2010.498860","volume":"22","author":"LS Eller","year":"2010","unstructured":"Eller LS, Bunch EH, Wantland DJ, Portillo CJ, Reynolds NR, Nokes KM, Coleman CL, Kemppainen JK, Kirksey KM, Corless IB, Hamilton MJ, Dole PJ, Nicholas PK, Holzemer WL, Tsai YF (2010) Prevalence, correlates, and self-management of HIV-related depressive symptoms. AIDS Care 22:1159\u20131170. \nhttps:\/\/doi.org\/10.1080\/09540121.2010.498860","journal-title":"AIDS Care"},{"key":"9657_CR21","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2165\/00003088-200241150-00002","volume":"41","author":"CL DeVane","year":"2002","unstructured":"DeVane CL, Liston HL, Markowitz JS (2002) Clinical pharmacokinetics of sertraline. Clin Pharmacokinet 41:1247\u20131266. \nhttps:\/\/doi.org\/10.2165\/00003088-200241150-00002","journal-title":"Clin Pharmacokinet"},{"key":"9657_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO (2011) Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J 13:143\u2013151. \nhttps:\/\/doi.org\/10.1208\/s12248-011-9255-z","journal-title":"AAPS J"},{"key":"9657_CR23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10928-016-9487-8","volume":"43","author":"A-G Dosne","year":"2016","unstructured":"Dosne A-G, Bergstrand M, Harling K, Karlsson MO (2016) Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling. J Pharmacokinet Pharmacodyn 43:583\u2013596. \nhttps:\/\/doi.org\/10.1007\/s10928-016-9487-8","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9657_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/mmy\/myv104","volume":"54","author":"J Dyal","year":"2016","unstructured":"Dyal J, Akampurira A, Rhein J, Morawski BM, Kiggundu R, Nabeta HW, Musubire AK, Bahr NC, Williams DA, Bicanic T, Larsen RA, Meya DB, Boulware DR (2016) Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis. Med Mycol 54:361\u2013369. \nhttps:\/\/doi.org\/10.1093\/mmy\/myv104","journal-title":"Med Mycol"},{"key":"9657_CR25","unstructured":"National Committee for Clinical Laboratory Standards (1997) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard. Wayne, PA Natl Comm Clin Lab Stand NCCLS:M27-A"},{"key":"9657_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2014.27","author":"EL Plan","year":"2014","unstructured":"Plan EL (2014) Modeling and simulation of count data. CPT Pharmacomet Syst Pharmacol. \nhttps:\/\/doi.org\/10.1038\/psp.2014.27","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"9657_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/psp.2013.18","volume":"2","author":"N Holford","year":"2013","unstructured":"Holford N (2013) A time to event tutorial for pharmacometricians. CPT Pharmacomet Syst Pharmacol 2:1\u20138","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"9657_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cmpb.2003.11.003","volume":"75","author":"L Lindbom","year":"2004","unstructured":"Lindbom L, Ribbing J, Jonsson EN (2004) Perl-speaks-NONMEM (PsN)\u2014a Perl module for NONMEM related programming. Comput Methods Programs Biomed 75:85\u201394. \nhttps:\/\/doi.org\/10.1016\/j.cmpb.2003.11.003","journal-title":"Comput Methods Programs Biomed"},{"key":"9657_CR29","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1038\/psp.2013.24","volume":"2","author":"RJ Keizer","year":"2013","unstructured":"Keizer RJ, Karlsson MO, Hooker A (2013) Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose. CPT Pharmacomet Syst Pharmacol 2:e50. \nhttps:\/\/doi.org\/10.1038\/psp.2013.24","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"9657_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/bcp.12500","volume":"79","author":"JM Cooper","year":"2015","unstructured":"Cooper JM, Duffull SB, Saiao AS, Isbister GK (2015) The pharmacokinetics of sertraline in overdose and the effect of activated charcoal. Br J Clin Pharmacol 79:307\u2013315. \nhttps:\/\/doi.org\/10.1111\/bcp.12500","journal-title":"Br J Clin Pharmacol"},{"key":"9657_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/0091270012445793","author":"CH Li","year":"2012","unstructured":"Li CH, Pollock BG, Lyketsos CG, Vaidya V, Drye LT, Kirshner M, Sorisio D, Bies RR (2012) Population pharmacokinetic modeling of sertraline treatment in patients with alzheimer disease: the DIADS-2 study. J Clin Pharmacol XX: \nhttps:\/\/doi.org\/10.1177\/0091270012445793","journal-title":"J Clin Pharmacol XX:"},{"key":"9657_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/clpt.2011.249","volume":"91","author":"V Michaud","year":"2012","unstructured":"Michaud V, Ogburn E, Thong N, Aregbe AO, Quigg TC, Flockhart DA, Desta Z (2012) Induction of CYP2C19 and CYP3A activity following repeated administration of efavirenz in healthy volunteers. Clin Pharmacol Ther 91:475\u2013482. \nhttps:\/\/doi.org\/10.1038\/clpt.2011.249","journal-title":"Clin Pharmacol Ther"},{"key":"9657_CR33","first-page":"763","volume":"27","author":"K Kobayashi","year":"1999","unstructured":"Kobayashi K, Ishizuka T, Shimada N, Yoshimura Y, Kamijima K, Chiba K (1999) Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro. Drug Metab Dispos 27:763\u2013766","journal-title":"Drug Metab Dispos"},{"key":"9657_CR34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1124\/dmd.104.002428.chrome","volume":"33","author":"RS Obach","year":"2005","unstructured":"Obach RS, Cox LM, Tremaine LM (2005) Sertraline is metabolized by multiple cytochrome p450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. Drug Metab Dispos 33:262\u2013270. \nhttps:\/\/doi.org\/10.1124\/dmd.104.002428.chrome","journal-title":"Drug Metab Dispos"},{"key":"9657_CR35","volume-title":"Report from dose finding workshop","author":"EMA","year":"2014","unstructured":"EMA (2014) Report from dose finding workshop. EMA, London"},{"key":"9657_CR36","first-page":"1","volume-title":"Zoloft (sertraline HCl) [package Insert]","author":"Zoloft (sertraline HCl) [package Insert]","year":"2019","unstructured":"Zoloft (sertraline HCl) [package Insert] (2019) Zoloft (sertraline HCl) [package Insert]. NY Pfizer, New York, pp 1\u201335"},{"key":"9657_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6640-7_8","author":"AJ Lepak","year":"2014","unstructured":"Lepak AJ, Andes DR (2014) Antifungal pharmacokinetics and pharmacodynamics. Essent Clin Mycol Second Ed. \nhttps:\/\/doi.org\/10.1007\/978-1-4419-6640-7_8","journal-title":"Essent Clin Mycol Second Ed"},{"key":"9657_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0034-5288(02)00039-5","volume":"73","author":"PL Toutain","year":"2002","unstructured":"Toutain PL, Del Castillo JRE, Bousquet-M\u00e9lou A (2002) The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Res Vet Sci 73:105\u2013114","journal-title":"Res Vet Sci"},{"key":"9657_CR39","doi-asserted-by":"publisher","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","volume":"84","author":"F Thiebaut","year":"1987","unstructured":"Thiebaut F, Tsuruot T, Hamadat H, Gottesman MM, Pastan IRA (1987) Cellular localization of multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci 84:7735\u20137738. \nhttps:\/\/doi.org\/10.1073\/pnas.84.21.7735","journal-title":"Proc Natl Acad Sci"},{"key":"9657_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","volume":"36","author":"AH Schinkel","year":"1999","unstructured":"Schinkel AH (1999) P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 36:179\u2013194. \nhttps:\/\/doi.org\/10.1016\/S0169-409X(98)00085-4","journal-title":"Adv Drug Deliv Rev"},{"key":"9657_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1128\/AAC.46.1.160-165.2002","volume":"46","author":"EJ Wang","year":"2002","unstructured":"Wang EJ, Lew K, Casciano CN, Clement RP, Johnson WW (2002) Interaction of common azole antifungals with P glycoprotein. Antimicrob Agents Chemother 46:160\u2013165. \nhttps:\/\/doi.org\/10.1128\/AAC.46.1.160-165.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"9657_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1371\/journal.pone.0056525","volume":"8","author":"A Kapoor","year":"2013","unstructured":"Kapoor A, Iqbal M, Petropoulos S, Ho HL, Gibb W, Matthews SG (2013) Effects of sertraline and fluoxetine on P-glycoprotein at barrier sites. In vivo and in vitro approaches. PLoS ONE 8:3\u20138. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0056525","journal-title":"PLoS ONE"},{"key":"9657_CR43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1124\/jpet.102.046532","volume":"305","author":"J Weiss","year":"2003","unstructured":"Weiss J, Dormann S-MG, Martin-Facklam M, Kerpen CJ, Ketabi-Kiyanvash N, Haefeli WE (2003) Inhibition of P-glycoprotein by newer antidepressants. J Pharmacol Exp Ther 305:197\u2013204. \nhttps:\/\/doi.org\/10.1124\/jpet.102.046532","journal-title":"J Pharmacol Exp Ther"},{"key":"9657_CR44","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S1473-3099(16)30321-8","volume":"16","author":"A Veringa","year":"2016","unstructured":"Veringa A, van der Elst KCM, Day JN, Thwaites GE, Alffenaar JWC (2016) Sertraline for HIV-associated cryptococcal meningitis. Lancet Infect Dis 16:1111","journal-title":"Lancet Infect Dis"},{"key":"9657_CR45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/clpt.2013.34","volume":"94","author":"JC Kalvass","year":"2013","unstructured":"Kalvass JC, Polli JW, Bourdet DL, Feng B, Huang S-M, Liu X, Smith QR, Zhang LK, Zamek-Gliszczynski MJ (2013) Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: the ITC evidence-based position. Clin Pharmacol Ther 94:80\u201394. \nhttps:\/\/doi.org\/10.1038\/clpt.2013.34","journal-title":"Clin Pharmacol Ther"},{"key":"9657_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pharmthera.2009.03.017","volume":"123","author":"S Eyal","year":"2009","unstructured":"Eyal S, Hsiao P, Unadkat JD (2009) Drug interactions at the blood-brain barrier: fact or fantasy? Pharmacol Ther 123:80\u2013104. \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2009.03.017","journal-title":"Pharmacol Ther"},{"key":"9657_CR47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/apha.12430","volume":"213","author":"MS Shajib","year":"2015","unstructured":"Shajib MS, Khan WI (2015) The role of serotonin and its receptors in activation of immune responses and inflammation. Acta Physiol (Oxf) 213:561\u2013574. \nhttps:\/\/doi.org\/10.1111\/apha.12430","journal-title":"Acta Physiol (Oxf)"},{"key":"9657_CR48","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1160\/TH14-01-0074","volume":"112","author":"C Speth","year":"2014","unstructured":"Speth C, Rambach G, Lass-Fl\u00f6rl C (2014) Platelet immunology in fungal infections. Thromb Haemost 112:632\u2013639. \nhttps:\/\/doi.org\/10.1160\/TH14-01-0074","journal-title":"Thromb Haemost"},{"key":"9657_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.coph.2011.01.006","volume":"11","author":"CP Mercado","year":"2011","unstructured":"Mercado CP, Ziu E, Kilic F (2011) Communication between 5-HT and small GTPases. Curr Opin Pharmacol 11:23\u201328. \nhttps:\/\/doi.org\/10.1016\/j.coph.2011.01.006","journal-title":"Curr Opin Pharmacol"},{"key":"9657_CR50","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/jnr.490230410","volume":"23","author":"M Larsson","year":"1989","unstructured":"Larsson M, Hagberg L, Norkrans G, Forsman A (1989) Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection. J Neurosci Res 23:441\u2013446. \nhttps:\/\/doi.org\/10.1002\/jnr.490230410","journal-title":"J Neurosci Res"},{"key":"9657_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02166.x","volume":"115","author":"EJ Meredith","year":"2005","unstructured":"Meredith EJ, Chamba A, Holder MJ, Barnes NM, Gordon J (2005) Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 115:289\u2013295","journal-title":"Immunology"},{"key":"9657_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1021\/cn300186b","volume":"4","author":"NL Baganz","year":"2013","unstructured":"Baganz NL, Blakely RD (2013) A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci 4:48\u201363","journal-title":"ACS Chem Neurosci"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-019-09657-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-019-09657-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-019-09657-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T23:28:31Z","timestamp":1601681311000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-019-09657-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9657"],"URL":"https:\/\/doi.org\/10.1007\/s10928-019-09657-0","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,4]]},"assertion":[{"value":"15 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}